Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    26 September 2024

    Transforming healthcare: the power of purpose-led partnerships

    In this episode, ⁠Dr Bipin Patel⁠ sits down with ⁠Samuel Hollis⁠, Country President and Managing Director at ⁠Novartis⁠ to explore the key elements of forming impactful healthcare partnerships. ...

    26 September 2024

    Enterprise Therapeutics granted ‘rare pediatric disease designation’ in the US for novel cystic fibrosis investigational therapy ETD001

    ETD001 is a novel, first in class blocker of the epithelial sodium channel (ENaC) aimed at treating people with cystic fibrosis without current effective therapies ETD001 commenced Phase 2 clinical trials in July 2024, expected to complete in 2025 Brighton, UK: Enterprise Therapeu...

    25 September 2024

    Takeda’s Qdenga® - more campaigns needed before single-dose products arrive

    This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis publishes a brand-new global analysis of the dengue endemic vaccines market. ...

    24 September 2024

    Steritas’ Pediatric Glucocorticoid Toxicity Index used by Alder Hey and Liverpool Trials Centre to assess steroid toxicity in children with juvenile idiopathic arthritis

    Study will allow researchers to assess the outcomes of intravenous and oral glucocorticoid protocols in children ...

    23 September 2024

    Broken String Biosciences appoints Laurence Reid and Brad Crutchfield to its Board of Directors

    Laurence Reid joins as Chairman, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Third Rock Ventures Brad Crutchfield appointed as Non-Executive Director, previously 10x Genomics, QIAGEN, Illumina, and Bio-Rad Laboratories Cambridge, UK, 23 September 2024: Broken Str...

    20 September 2024

    Teaching the next generation of innovators...

    Why does the planet need entrepreneurship? What can the next generation of innovators learn from big businesses? ...

    23 September 2024

    Give your cleanroom the TLC it needs with Guardtech’s first-class decontamination programmes and elite furniture fit-outs

    The Guardtech Group are urging clients to ensure their controlled environments are free of contamination and fully equipped to deliver the best results ...

    19 September 2024

    FUJIFILM Irvine Scientific develops Oceo Rover: the first automated single-use hydration system for media and buffers

    Oceo Rover automates and simplifies hydration of powdered media and buffers, to optimize bioprocessing workflows Automated system harnesses single-use technology to reduce risks associated with variability, contamination and safety within biopharmaceutical manufacturing processes S...

    13 September 2024

    Pioneering Cambridge VR project announces London tour

    Innovative virtual reality platform rapidly transforms users into confident and skilled public speakers. The multi-award-winning Immersive Technology Lab at Lucy Cavendish College, University of Cambridge, is set to embark on a London tour, showcasing its groundbreaking work in leverag...

    18 September 2024

    Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy development

    High performance two-plasmid production system achieves E12 vg/mL unconcentrated titers AI-driven design tools to improve expression precision, efficacy, and manufacturability Boston, Massachusetts, 18 Sep 2024: Asimov, the synthetic biology company advancing the design and produc...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 132
    • Page 133
    • Current page 134
    • Page 135
    • Page 136
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS